Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL58805 in Advanced GYN, STS, or Breast Cancers
NCT07811232Phase 2Not yet recruiting
- Sponsor
- Advenchen Laboratories
- Start
- Sep 2026
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
A Phase 2 trial of AL58805 in endometrial cancer (EC), Cervical Cancer (CC), soft tissue sarcoma (STS), breast cancer, sponsored by Advenchen Laboratories. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
AL58805
03
Conditions
endometrial cancer (EC)Cervical Cancer (CC)soft tissue sarcoma (STS)breast cancer
Beyond the preview
Go deeper on NCT07811232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07811232.